Acadia Healthcare Company, Inc.

ACHC

HealthcareMid CapUS Equities · NYSE / NASDAQ

AI Agents

Company Profile

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

Valuation

Market Cap$2.3B

Current Price$23.88as of Jun 23, 2026

P/E Ratio-2.10

P/B Ratio1.19

EV / EBITDA-6.55

EV / Sales1.46

Profitability

Operating Margin11.7%

Net Profit Margin-33.3%

EBITDA Margin-22.3%

Returns

ROE-56.6%

ROCE7.8%

ROIC %-

ROA-20.0%

Solvency

Current Ratio1.55

Debt / Equity1.36

Debt / Assets0.48

CFO / Net Profit-0.12

Price History▲ 14.53% over 1Y

Technical Chart

Historical Performance Charts

5-year financial trends. Figures in USD millions.

Revenue vs Net Profit (5Y)

Free Cash Flow vs Operating Cash Flow (5Y)

Operating Margin % (5Y)

Growth Summary

Latest fiscal year: 2025

Revenue$3.3B▲ 5.0%

EBITDA$-738M▼ 221.4%

Net Profit$-1.1B▼ 531.4%

Cash from Ops (CFO)$132M▲ 1.7%

Free Cash Flow (FCF)$-440M▼ 21.5%

Revenue CAGR 3Y8.3%

Revenue CAGR 5Y-

Net Profit CAGR 3Y-

Net Profit CAGR 5Y-

Historical Growth

Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)

Year	Revenue	EBITDA	Net Profit	FCF	ROE	Rev Growth 1Y	NP Growth 1Y
2025	$3.3B	$-738M	$-1.1B	$-440M	-56.6%	5.0%	-531.4%
2024	$3.2B	$608M	$256M	$-561M	8.3%	7.7%	-1279.7%
2023	$2.9B	$189M	$-22M	$38M	-0.8%	12.2%	-107.9%
2022	$2.6B	$562M	$273M	$84M	9.7%	-	-

Financial Statements

Income statement, balance sheet, and cash flow as reported

Consolidated Figures in USD Millions.

Metric	2021	2022	2023	2024	2025
Total Revenue	-	2,610.40	2,928.74	3,153.96	3,312.77
Operating Revenue	-	2,610.40	2,928.74	3,153.96	3,312.77
Cost Of Revenue	-	100.20	105.99	112.71	118.05
Gross Profit	-	2,510.20	2,822.75	3,041.25	3,194.72
Operating Expense	-	2,042.50	2,309.73	2,518.97	2,806.76
Selling General And Administration	-	1,596.91	1,794.90	1,928.59	2,064.20
Total Expenses	-	2,142.70	2,415.72	2,631.69	2,924.80
Operating Income	-	467.70	513.02	522.28	387.96
EBITDA	-	561.67	189.11	607.84	-737.83
Normalized EBITDA	-	585.46	645.36	671.87	577.21
EBIT	-	443.90	56.76	458.25	-927.08
Interest Expense	-	69.76	82.12	116.37	138.86
Net Interest Income	-	-69.76	-82.12	-116.37	-138.86
Other Non Operating Income Expenses	17.90	-	-	-	-
Other Income Expense	-	-23.79	-456.25	-64.03	-1,315.04
Interest Expense Non Operating	-	69.76	82.12	116.37	138.86
Net Non Operating Interest Income Expense	-	-69.76	-82.12	-116.37	-138.86
Pretax Income	-	374.14	-25.36	341.88	-1,065.94
Tax Provision	-	94.11	-9.70	77.40	25.98
Tax Rate For Calcs	-	0	0	0	0
Tax Effect Of Unusual Items	-	-6	-174.29	-14.47	-276.16
Net Income Continuous Operations	-	280.03	-15.66	264.48	-1,091.92
Net Income From Continuing And Discontinued Operation	-	273.14	-21.67	255.61	-1,102.77
Net Income From Continuing Operation Net Minority Interest	-	273.14	-21.67	255.61	-1,102.77
Net Income	-	273.14	-21.67	255.61	-1,102.77
Net Income Common Stockholders	-	273.14	-21.67	255.61	-1,102.77
Net Income Including Noncontrolling Interests	-	280.03	-15.66	264.48	-1,091.92
Normalized Income	-	290.94	260.30	305.17	-63.89
Diluted NI Availto Com Stockholders	-	273.14	-21.67	255.61	-1,102.77
Basic Average Shares	-	89.68	90.95	91.62	90.70
Diluted Average Shares	-	91.56	90.95	92.06	90.70
Reconciled Depreciation	-	117.77	132.35	149.60	189.25
Reconciled Cost Of Revenue	-	100.20	105.99	112.71	118.05
Total Unusual Items	-	-23.79	-456.25	-64.03	-1,315.04
Total Unusual Items Excluding Goodwill	-	-23.79	-456.25	-64.03	-1,315.04
Minority Interests	-	-6.89	-6.01	-8.87	-10.85
Net Income Discontinuous Operations	-12.64	0	0	-	-
Special Income Charges	-	-23.79	-456.25	-64.03	-1,315.04
Other Special Charges	-	0.50	412.98	30.62	287.49
Write Off	-	0	9.79	17.28	1,007.89
Impairment Of Capital Assets	24.29	0	-	-	-
Restructuring And Mergern Acquisition	-	23.29	43.23	16.13	28.37
Depreciation Amortization Depletion Income Statement	-	117.77	132.35	149.60	189.25
Depreciation And Amortization In Income Statement	-	117.77	132.35	149.60	189.25
General And Administrative Expense	-	1,596.91	1,794.90	1,928.59	2,064.20
Other Gand A	-	158.01	176.01	189.71	195.48
Salaries And Wages	-	1,393.43	1,572.33	1,691.02	1,820.70
Gain On Sale Of Ppe	-	0	9.75	0	8.72
Rent Expense Supplemental	-	45.46	46.55	47.86	48.02
Other Operating Expenses	-	327.83	382.49	440.79	553.31
Rent And Landing Fees	-	45.46	46.55	47.86	48.02

Peer Comparison

Healthcare sector peers, ranked by market cap

Company	Ticker	Market Cap	P/E	P/B	ROE	EV/EBITDA
Acadia Healthcare Company, Inc.this co.	ACHC	$2.3B	-2.10	1.19	-56.6%	-6.55
Privia Health Group, Inc.	PRVA	$2.7B	117.50	3.65	3.1%	50.35
Supernus Pharmaceuticals, Inc.	SUPN	$2.6B	-67.30	2.44	-3.6%	58.94
TransMedics Group, Inc.	TMDX	$2.5B	12.96	5.21	40.2%	16.82
Prestige Consumer Healthcare Inc.	PBH

Learn while you research

Hand-picked academy chapters to deepen your understanding of Acadia Healthcare Company, Inc. and the metrics that matter.

01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read 02 Sector Analysis Matters

Loading…

Year

Revenue

EBITDA

Net Profit

FCF

ROE

Rev Growth 1Y

NP Growth 1Y

2025

$3.3B

$-738M

$-1.1B

$-440M

-56.6%

5.0%

-531.4%

2024

$3.2B

$608M

$256M

$-561M

8.3%

7.7%

-1279.7%

2023

$2.9B

$189M

$-22M

$38M

-0.8%

12.2%

-107.9%

2022

$2.6B

$562M

$273M

$84M

9.7%

Metric

2021

2022

2023

2024

2025

Total Revenue

2,610.40

2,928.74

3,153.96

3,312.77

Operating Revenue

2,610.40

2,928.74

3,153.96

3,312.77

Cost Of Revenue

100.20

105.99

112.71

118.05

Gross Profit

2,510.20

2,822.75

3,041.25

3,194.72

Operating Expense

2,042.50

2,309.73

2,518.97

2,806.76

Selling General And Administration

1,596.91

1,794.90

1,928.59

2,064.20

Total Expenses

2,142.70

2,415.72

2,631.69

2,924.80

Operating Income

467.70

513.02

522.28

387.96

EBITDA

561.67

189.11

607.84

-737.83

Normalized EBITDA

585.46

645.36

671.87

577.21

EBIT

443.90

56.76

458.25

-927.08

Interest Expense

69.76

82.12

116.37

138.86

Net Interest Income

-69.76

-82.12

-116.37

-138.86

Other Non Operating Income Expenses

17.90

Other Income Expense

-23.79

-456.25

-64.03

-1,315.04

Interest Expense Non Operating

69.76

82.12

116.37

138.86

Net Non Operating Interest Income Expense

-69.76

-82.12

-116.37

-138.86

Pretax Income

374.14

-25.36

341.88

-1,065.94

Tax Provision

94.11

-9.70

77.40

25.98

Tax Rate For Calcs

Tax Effect Of Unusual Items

-6

-174.29

-14.47

-276.16

Net Income Continuous Operations

280.03

-15.66

264.48

-1,091.92

Net Income From Continuing And Discontinued Operation

273.14

-21.67

255.61

-1,102.77

Net Income From Continuing Operation Net Minority Interest

273.14

-21.67

255.61

-1,102.77

Net Income

273.14

-21.67

255.61

-1,102.77

Net Income Common Stockholders

273.14

-21.67

255.61

-1,102.77

Net Income Including Noncontrolling Interests

280.03

-15.66

264.48

-1,091.92

Normalized Income

290.94

260.30

305.17

-63.89

Diluted NI Availto Com Stockholders

273.14

-21.67

255.61

-1,102.77

Basic Average Shares

89.68

90.95

91.62

90.70

Diluted Average Shares

91.56

90.95

92.06

90.70

Reconciled Depreciation

117.77

132.35

149.60

189.25

Reconciled Cost Of Revenue

100.20

105.99

112.71

118.05

Total Unusual Items

-23.79

-456.25

-64.03

-1,315.04

Total Unusual Items Excluding Goodwill

-23.79

-456.25

-64.03

-1,315.04

Minority Interests

-6.89

-6.01

-8.87

-10.85

Net Income Discontinuous Operations

-12.64

Special Income Charges

-23.79

-456.25

-64.03

-1,315.04

Other Special Charges

0.50

412.98

30.62

287.49

Write Off

9.79

17.28

1,007.89

Impairment Of Capital Assets

24.29

Restructuring And Mergern Acquisition

23.29

43.23

16.13

28.37

Depreciation Amortization Depletion Income Statement

117.77

132.35

149.60

189.25

Depreciation And Amortization In Income Statement

117.77

132.35

149.60

189.25

General And Administrative Expense

1,596.91

1,794.90

1,928.59

2,064.20

Other Gand A

158.01

176.01

189.71

195.48

Salaries And Wages

1,393.43

1,572.33

1,691.02

1,820.70

Gain On Sale Of Ppe

9.75

8.72

Rent Expense Supplemental

45.46

46.55

47.86

48.02

Other Operating Expenses

327.83

382.49

440.79

553.31

Rent And Landing Fees

45.46

46.55

47.86

48.02

Company

Ticker

Market Cap

P/E

P/B

ROE

EV/EBITDA

Acadia Healthcare Company, Inc.this co.

ACHC

$2.3B

-2.10

1.19

-56.6%

-6.55

Privia Health Group, Inc.

PRVA

$2.7B

117.50

3.65

3.1%

50.35

Supernus Pharmaceuticals, Inc.

SUPN

$2.6B

-67.30

2.44

-3.6%

58.94

TransMedics Group, Inc.

TMDX

$2.5B

12.96

5.21

40.2%

16.82

Prestige Consumer Healthcare Inc.

PBH

Acadia Healthcare Company, Inc.

Valuation

Profitability

Returns

Solvency

Historical Performance Charts

Revenue vs Net Profit (5Y)

Free Cash Flow vs Operating Cash Flow (5Y)

Operating Margin % (5Y)

Growth Summary

Historical Growth

Financial Statements

Peer Comparison

Acadia Healthcare Company, Inc.

Valuation

Profitability

Returns

Solvency

Historical Performance Charts

Revenue vs Net Profit (5Y)

Free Cash Flow vs Operating Cash Flow (5Y)

Operating Margin % (5Y)

Growth Summary

Historical Growth

Financial Statements

Peer Comparison

Key concepts to brush up on